Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Paccola: Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic.... (0.14 sec) 

Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular …


L Paccola, RA Costa, MS Folgosa, JC Barbosa, … - British Journal of Ophthalmology, 2008 - bjo.bmj.com
Results: Twenty-six patients (26 eyes) completed all study visits (two patients
missed two consecutive study visits). Central macular thickness was
significantly reduced in the intravitreal triamcinolone group compared with ...
Cited by 31 - Related articles - BL Direct - All 5 versions

Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; …


H Ahmadieh, A Ramezani, N Shoeibi, B … - Graefe's Archive for Clinical and Experimental …, 2008 - Springer
DME were included. Subjects were randomly assigned to one of the three study
arms: 1) three injections of IVB (1.25 mg/0.05 ml) at 6-week intervals, 2)
combined IVB and IVT (1.25 mg/0.05 ml and 2 mg/0.05 ml respectively) ...
Cited by 21 - Related articles - BL Direct - All 3 versions

Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on …


M Shimura, T Nakazawa, K Yasuda, T Shiono, … - American journal of ophthalmology, 2008 - Elsevier
Before the injection, foveal thickness and VA were 522.3 ± 91.3 μm and 0.64 ±
0.28 μm in the triamcinolone-injected eye, and 527.6 ± 78.8 μm and 0.61 ±
0.18 μm in the bevacizumab-injected eye, respectively; there was no ...
Cited by 36 - Related articles - All 34 versions

Intravitreal bevacizumab (Avastin) injection alone or combined with triamcinolone versus …

- prsjournal.com
M Soheilian, A Ramezani, B Bijanzadeh, M … - Retina, 2007 - journals.lww.com
From the *Ophthalmology Department and Ophthalmic Research Center, Labbafinejad
Medical Center, Shaheed Beheshti Medical University, Tehran, Iran; †Negah Eye
Hospital, Tehran, Iran; and the ‡Department of Ophthalmology, University ...
Cited by 23 - Related articles - BL Direct - All 6 versions

Intravitreal Triamcinolone versus Bevacizumab


L Paccola, RA Costa, MS Folgosa… - bjo.bmj.com
L Paccola, RA Costa, MS Folgosa, et al. ... References http://bjo.bmj.com/
content/92/1/76.full.html#ref-list-1 This article cites 28 articles, 8 of which
can be accessed free at: ... Articles on similar topics can be found in ...
Related articles - All 2 versions

Efficacy of 1.25 MG versus 2.5 MG intravitreal bevacizumab for diabetic macular edema: six- …

- prsjournal.com
DSC LAM, TYY LAI, VYW LEE, CKM CHAN, … - Retina, 2009 - journals.lww.com
From the *Department of Ophthalmology and Visual Sciences, the Chinese
University of Hong Kong, Hong Kong; †Hong Kong Eye Hospital, Kowloon, Hong
Kong; and ‡Prince of Wales Hospital, Shatin, New Territories, Hong Kong.
Cited by 3 - Related articles - All 5 versions

Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone …


DSC Lam, CKM Chan, S Mohamed, TYY Lai, … - Ophthalmology, 2007 - Elsevier
Presented in part at: 2nd Singapore Eye Research Institute–Association for
Research in Vision and Ophthalmology Meeting on Research in Vision and
Ophthalmology, February 2005, Singapore; 20th Asia Pacific Academy of ...
Cited by 20 - Related articles - All 10 versions

Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: …


A Mirshahi, R Roohipoor, A Lashay, SF … - European journal of ophthalmology - ncbi.nlm.nih.gov
PURPOSE: To evaluate the additional therapeutic effect of single intravitreal
bevacizumab injection on standard laser treatment in the management of
proliferative diabetic retinopathy. METHODS: A prospective, fellow-eye sham ...
Cited by 12 - Related articles - BL Direct

Intravitreal triamcinolone acetonide for diabetic retinopathy


J Jonas - Developments in Ophthalmology, 2007 - content.karger.com
Abstract Intravitreal triamcinolone acetonide (IVTA) has been applied in
exponentially increas- ing frequency for various intraocular neovascular and
edematous diseases, including diabetic macular edema, proliferating ...
Cited by 21 - Related articles - BL Direct - All 5 versions

Intravitreal bevacizumab treatment for refractory diabetic macular edema


K Örnek, N Örnek - Journal of Ocular Pharmacology and Therapeutics, 2008 - liebertonline.com
Introduction D IABETIC MACULAR EDEMA (DME) is still the main cause of visual
loss in patients with diabetic retinopathy. Treat- ment of DME includes macular
laser photocoagulation (MLP), pars plana vitrectomy (PPV), and the ...
Cited by 4 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google